Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients

Table 2

Prevalence of metabolic alterations before and after liver transplantation.

	Absent pre-OLT and post-OLT	Present pre-OLT and absent post-OLT	Present pre-OLT and present post-OLT	Absent pre-OLT and present post-OLT(de novo)
		(Prevalent cases)		(Incident cases)
Diabetes mellitus type 2; N (%)	189 (53.1)	8 (2.2)	85 (23.9)	74 (20.8); AR = 74/263 = 28.1%
Hypertension; N (%)	140 (39.3)	6 (1.7)	67 (18.8)	143 (40.2); AR = 143/283 = 50.5%
Dyslipidemia; N (%)	189 (53.1)	3 (0.8)	11 (3.1)	153 (43); AR = 153/342 = 44.7%
MAFLD; N (%)	179 (50.3)	10 (2.8)	10 (2.8)	57 (16); AR = 57/236 = 24.2%
Metabolic syndrome; N (%)	271 (84.2%)	6 (1.9)	11 (3.4)	34 (10.6); AR = 34/305 = 11.1%

AR, absolute risk: this measure was computed for incident cases, thus excluding prevalent cases at baseline.